AstraZeneca’s ASH 2023: Surging Hematology Innovations
At the upcoming 65th American Society of Hematology (ASH) Annual Meeting, AstraZeneca will present a wealth of new clinical...
DCTs are in Dire Need: Embrace Diversity Now
At the inaugural Black Women in Clinical Research conference, Dr. Jayne Morgan, an acclaimed cardiologist and health educator, delivered...
FDA on DCTs: Charting the Course for Innovative Trials
The 2023 Decentralized Trials & Research Alliance Summit (DTRA) marked a significant juncture in clinical research, particularly through its panel discussion...
DCTs: Washington’s Jubilant Journey To Revolutionize Trials
The 2023 Decentralized Trials & Research Alliance (DTRA) Annual Meeting featured a pivotal moment in clinical research with a...
Digital Therapeutic Clinical Trials: A Pioneering Approach to Better Treatments
In this engaging discussion, we delve into the dynamic and evolving world of digital therapeutic (DTx) and decentralized clinical...
Sunshine Act Compliance: A Better Empowerment for Life Science Companies
The origins of the Sunshine Act can be traced back to growing calls for transparency in healthcare and Life...
RWE: A Beacon Of Hope For NHS Clinical Trials
In an era where Real-World Evidence (RWE) is revolutionizing clinical trials, our interview with Tina Marshall, a key figure...
Google’s AI: Redefining the Future of Clinical Trials One Breakthrough at a Time
The 2023 CNS Summit featured a significant panel discussion on the future of clinical trials led by Isaac Galatzer-Levy,...
Microsoft’s Perspective For AI in Clinical Trials
The 2023 CNS Summit featured a panel with Microsoft, marking a significant milestone in understanding AI in clinical trials....
Psychedelics: A Beacon of Hope for Mental Health
The 2023 CNS Summit hosted a pivotal session that illuminated the evolving landscape of clinical trials and drug development...